This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): SelCID CC-1088
Description: SelCIDs are potent, orally available inhibitors of tumor necrosis factor alpha (TNF alpha) and phosphodiesterase type four (PDE 4), cytokines that have been linked to the onset and progression of cancer and inflammatory diseases.
Additional information available to subscribers only: